An international team of researchers have found that simple oral hygiene could help reduce the severity of COVID-19.
A new study reveals that intestinal worm infections can leave women in sub-Saharan Africa more vulnerable to sexually-transmitted viral infections.
The University of Birmingham's School of Pharmacy finished second nationally out of 29 Schools of Pharmacy who participated in the national pre-registration pharmacist recruitment exam in 2020/21.
Latest study finds over-80's receiving a dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
Dr Julie Rayes was awarded a reputable Fellowship to study, test and repurpose drugs to limit thrombo-inflammation caused by infection or congenital disorders.
The University of Birmingham and Birmingham City Council have set up a research project to improve people's experiences of Lateral Flow Testing in Birmingham.
New study finds long-term stroke risk for patients with traumatic brain injuries in the four months after injury and is significant for up to five years.
A University of Birmingham-led study has found that 98% of over-80's who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.
A new EU-funded collaborative research project will develop the first integrative digital platform for diagnosing atrial cardiomyopathy.
Patients with lupus are more likely to have metabolic syndrome and insulin resistance – both factors linked to heart disease – if they have lower vitamin D levels, a new study reveals.
University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.
A clinical trial led by the University of Birmingham aims to find the best surgical treatments to prevent blindness in patients with a neurological condition.